All Articles

New trial data shows Sequel Med Tech's twiist™ AID system could bring much-needed simplicity and safety to millions with insulin-treated type 2 diabetes.

Global outdoor brand BLACKYAK moves beyond declarations, taking its climate summit to the Himalayan frontlines to launch a concrete action plan with local communities.

A key hospitality tech acquisition signals a major shift from fixing Wi-Fi problems to proactively validating the entire network, a move with broad implications.

With its new ISED-certified Private 5G portfolio for Canada's NCL band, Ontario's BLiNQ Networks is poised to drive industrial automation and smart city growth.

As the Pentagon scrambles for battle-tested autonomous weapons, a new partnership promises to deliver. But is fast-tracking foreign tech the answer or a risky bet?

A landmark study validates Ceribell's AI in predicting neurological outcomes, signaling a major shift in critical care and bolstering its competitive edge.

Medtronic veteran Jesse Litwak joins ProVerum, a move signaling the BPH innovator is shifting from R&D to aggressive commercial scale-up with its new ProVee tech.

CAMIN’s appointment of Tom Parks as CFO is more than a personnel change. It's a clear signal of a strategic bet on technology to redefine a critical global industry.

Beyond a simple plea for donations, Héma-Québec is executing a sophisticated strategic campaign to secure Quebec's most vital, and volatile, supply chain.

Ares Capital, a giant in middle-market finance, just opened a new $1B funding spigot. Is this a blueprint for the BDC industry or a sign of cheaper capital for American businesses?

Trane Technologies' latest report shows it's not just cutting emissions but building a profitable business model around it. A deep dive into their strategy.

Beyond the gridlock in Meriden lies a story of strategic ambition. A look at how Parsons' engineering and a massive state investment aim to redefine a vital corridor.

How new high-resolution analysis at Canadian GoldCamps' flagship project is de-risking a complex deposit and revealing its true high-grade potential.

With a new CMO known for getting drugs approved, Protego Biopharma is betting big on its novel approach to treating a devastating rare disease.

A CPG veteran launches Lioness, a functional gummy snack for women. Can timed ingredients and a massive retail launch redefine the wellness market?

Following its acquisition by Pearl Street Equity, Famous Brands brings in Richard Screnci to apply his QSR playbook to the iconic dessert franchises.

A routine board appointment at Bitcoin firm Twenty One Capital masks a major power shift. As Tether buys out SoftBank, is this a move toward legitimacy or a quiet coup?

With $173 million pouring into its tokenized SpaceX offering, MEXC is blurring the lines between crypto and Wall Street. But are retail investors buying a ticket to the moon or just a reflection of the rocket?

A new Texas hub isn't just about moving boxes. It's a strategic play to manage the complex, high-stakes lifecycle of hyperscale and AI infrastructure.

EQT appoints M&A mastermind Gustav Segerberg as CFO, signaling a doubling-down on its aggressive growth strategy. What does this mean for its future?